text_1: Using PET Scans to Discover Early Signs of Alzheimer’s
text_2: Alzheimer’s disease is a common and tragic disease. In spite of much research, there is currently little that can be done to stop or slow its progression. A hot area of research is in early detection. Two years ago, Medicare decided to cover PET scanning for diagnosing Alzheimer’s, with the hope that it could help with treatment and allow patients and their families to help with future planning. However, Medicare’s decision was very controversial and there are many issues surrounding the use of PET scanning for this conditon. This story does little to enlighten readers and is flawed in several ways. The story does not attempt to quantify the benefits of PET scanning. Most importantly, the story does not mention that even if Alzheimer’s is detected early, there is not much that can be done for it. The drug Aricept has only minor effects on the progression of the disease. Although the story mentions neurologic exams, the advantages and disadvantages of PET scanning compared to existing approaches are not described. How will the scanning fit in with current practice? These questions are not answered in the story. The story does not comment on the novelty or availability of PET scanning. Although the story hints at false alarms, this is insufficient information on the harms of scanning. How do such “false alarms” impact peoples’ lives? The story does quote two directors of major Alzheimer’s research centers. The story could have quoted other clinicians or researchers who could have provided some additional perspective. By accurately describing the prevalence of Alzheimer’s, the story avoids disease mongering. The story does mention that the scans are expensive – $1000 to $3500 and are not necessarily covered by insurance. The story could have provided costs of the traditional neurologic exam by comparison.